Aarey Drugs & Pharmaceuticals Yönetim
Yönetim kriter kontrolleri 4/4
Aarey Drugs & Pharmaceuticals' CEO is Mihir Ghatalia, appointed in Dec 2009, has a tenure of 14.92 years. total yearly compensation is ₹1.06M, comprised of 56.9% salary and 43.1% bonuses, including company stock and options. directly owns 16.49% of the company’s shares, worth ₹296.73M. The average tenure of the management team and the board of directors is 4.8 years and 4.6 years respectively.
Anahtar bilgiler
Mihir Ghatalia
İcra Kurulu Başkanı
₹1.1m
Toplam tazminat
| CEO maaş yüzdesi | 56.9% |
| CEO görev süresi | 14.9yrs |
| CEO sahipliği | 16.5% |
| Yönetim ortalama görev süresi | 4.8yrs |
| Yönetim Kurulu ortalama görev süresi | 4.6yrs |
Son yönetim güncellemeleri
Recent updates
CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | ₹52m |
| Mar 31 2024 | ₹1m | ₹600k | ₹47m |
| Dec 31 2023 | n/a | n/a | ₹29m |
| Sep 30 2023 | n/a | n/a | ₹24m |
| Jun 30 2023 | n/a | n/a | ₹37m |
| Mar 31 2023 | ₹1m | ₹600k | ₹38m |
| Dec 31 2022 | n/a | n/a | ₹27m |
| Sep 30 2022 | n/a | n/a | ₹41m |
| Jun 30 2022 | n/a | n/a | ₹48m |
| Mar 31 2022 | ₹2m | ₹600k | ₹66m |
| Dec 31 2021 | n/a | n/a | ₹87m |
| Sep 30 2021 | n/a | n/a | ₹85m |
| Jun 30 2021 | n/a | n/a | ₹77m |
| Mar 31 2021 | ₹1m | ₹602k | ₹65m |
| Dec 31 2020 | n/a | n/a | ₹61m |
| Sep 30 2020 | n/a | n/a | ₹58m |
| Jun 30 2020 | n/a | n/a | ₹51m |
| Mar 31 2020 | ₹1m | ₹600k | ₹58m |
| Dec 31 2019 | n/a | n/a | ₹55m |
| Sep 30 2019 | n/a | n/a | ₹57m |
| Jun 30 2019 | n/a | n/a | ₹65m |
| Mar 31 2019 | ₹2m | ₹600k | ₹65m |
| Dec 31 2018 | n/a | n/a | ₹66m |
| Sep 30 2018 | n/a | n/a | ₹69m |
| Jun 30 2018 | n/a | n/a | ₹64m |
| Mar 31 2018 | ₹300k | ₹300k | ₹62m |
Tazminat ve Piyasa: Mihir's total compensation ($USD12.55K) is below average for companies of similar size in the Indian market ($USD42.81K).
Tazminat ve Kazançlar: Mihir's compensation has been consistent with company performance over the past year.
CEO
Mihir Ghatalia (41 yo)
14.9yrs
Görev süresi
₹1,055,262
Tazminat
Mr. Mihir Rajesh Ghatalia, B.E., serves as an Executive Director at Worth Investment & Trading Company Limited. He has been the Managing Director at Aarey Drugs & Pharmaceuticals Ltd. since December 29, 20...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman & MD | 14.9yrs | ₹1.06m | 16.49% ₹ 296.7m | |
| Executive Director | 4.3yrs | ₹758.07k | Veri yok | |
| Chief Financial Officer | 3.8yrs | Veri yok | Veri yok | |
| Chief Accountant | 26.8yrs | Veri yok | Veri yok | |
| Company Secretary & Compliance Officer | 4.8yrs | ₹429.23k | Veri yok |
4.8yrs
Ortalama Görev Süresi
41yo
Ortalama Yaş
Deneyimli Yönetim: 524412's management team is considered experienced (4.8 years average tenure).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman & MD | 20.3yrs | ₹1.06m | 16.49% ₹ 296.7m | |
| Executive Director | 4.3yrs | ₹758.07k | Veri yok | |
| Non-Executive Independent Director | 4.8yrs | Veri yok | 0.0030% ₹ 53.3k | |
| Non Independent Non-Executive Woman Director | 1.1yrs | Veri yok | 14.12% ₹ 254.1m | |
| Non-Executive Independent Director | 16.4yrs | Veri yok | 1.06% ₹ 19.0m | |
| Independent Non Executive Director | 4.3yrs | Veri yok | Veri yok |
4.6yrs
Ortalama Görev Süresi
48.5yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: 524412's board of directors are considered experienced (4.6 years average tenure).